Gene · 5105
Papers3,855
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 3,855
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Sex differences in FASN protein concentrations in urinary exosomes related to serum triglycerides levels in healthy adults. | Lipids Health Dis | 2023 | 37858194 | PubTator, text mining | PubMed |
| FoxK1 associated gene regulatory network in hepatic insulin action and its relationship to FoxO1 and insulin receptor mediated transcriptional regulation. | Mol Metab | 2023 | 37852413 | PubTator, text mining | PubMed |
| ZNF692 organizes a hub specialized in 40S ribosomal subunit maturation enhancing translation in rapidly proliferating cells. | Cell Rep | 2023 | 37851577 | PubTator, text mining | PubMed |
| Overexpressing plant ferredoxin-like protein enhances photosynthetic efficiency and carbohydrates accumulation in Phalaenopsis. | Transgenic Res | 2023 | 37851307 | PubTator, text mining | PubMed |
| Nutrigenomics and redox regulation: Concepts relating to the Special Issue on nutrigenomics. | Redox Biol | 2023 | 37839954 | PubTator, text mining | PubMed |
| Functional Profiling of Soft Tissue Sarcoma Using Mechanistic Models. | Int J Mol Sci | 2023 | 37834179 | PubTator, text mining | PubMed |
| Joint analysis of the metabolomics and transcriptomics uncovers the dysregulated network and develops the diagnostic model of high-risk neuroblastoma. | Sci Rep | 2023 | 37813883 | PubTator, text mining | PubMed |
Revealing the Preventable Effects of Fu-Zheng-Qu-Xie Decoction against Recurrence and Metastasis of Postoperative Early-Stage Lung Adenocarcinoma Based on Network Pharmacology Coupled with Metabolomics Analysis. | ACS Omega | 2023 | 37810735 | PubTator, text mining | PubMed |
| Transcriptomics combined with physiological analysis reveals the mechanism of cadmium uptake and tolerance in Ligusticum chuanxiong Hort. under cadmium treatment. | Front Plant Sci | 2023 | 37810396 | PubTator, text mining | PubMed |
| Targeting Hippo signaling in cancer: novel perspectives and therapeutic potential. | MedComm (2020) | 2023 | 37799806 | PubTator, text mining | PubMed |
| Pyruvate kinase is post-translationally regulated by sirtuin 2 in Aedes aegypti mosquitoes. | Insect Biochem Mol Biol | 2023 | 37797713 | PubTator, text mining | PubMed |
| Hydroxymethylbutenyl diphosphate accumulation reveals MEP pathway regulation for high CO2-induced suppression of isoprene emission. | Proc Natl Acad Sci U S A | 2023 | 37782800 | PubTator, text mining | PubMed |
| Gαs is dispensable for β-arrestin coupling but dictates GRK selectivity and is predominant for gene expression regulation by β2-adrenergic receptor. | J Biol Chem | 2023 | 37774973 | PubTator, text mining | PubMed |
| Host and HBV Interactions and Their Potential Impact on Clinical Outcomes. | Pathogens | 2023 | 37764954 | PubTator, text mining | PubMed |
| Theabrownin from Dark Tea Ameliorates Insulin Resistance via Attenuating Oxidative Stress and Modulating IRS-1/PI3K/Akt Pathway in HepG2 Cells. | Nutrients | 2023 | 37764646 | PubTator, text mining | PubMed |
| Let-7g Upregulation Attenuated the KRAS-PI3K-Rac1-Akt Axis-Mediated Bioenergetic Functions. | Cells | 2023 | 37759534 | PubTator, text mining | PubMed |
| Prospects and perspectives: inferring physiological and regulatory targets for CAM from molecular and modelling approaches. | Ann Bot | 2023 | 37742290 | PubTator, text mining | PubMed |
| Hepatic retinaldehyde deficiency is involved in diabetes deterioration by enhancing PCK1- and G6PC-mediated gluconeogenesis. | Acta Pharm Sin B | 2023 | 37719384 | PubTator, text mining | PubMed |
| Bioinformatical analysis of the key differentially expressed genes for screening potential biomarkers in Wilms tumor. | Sci Rep | 2023 | 37717078 | PubTator, text mining | PubMed |
| Translational control of murine adiponectin expression by an upstream open reading frame element. | RNA Biol | 2023 | 37702393 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5105/papers?page=16